Search

Kishor Mayekar

Examiner (ID: 18425, Phone: (571)272-1339 , Office: P/1759 )

Most Active Art Unit
1795
Art Unit(s)
1759, 1102, 1741, 1754, 1795, 2741, 1753
Total Applications
2436
Issued Applications
1650
Pending Applications
176
Abandoned Applications
610

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3761834 [patent_doc_number] => 05852001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Method and compounds for inhibition of ribonucleases' [patent_app_type] => 1 [patent_app_number] => 8/772620 [patent_app_country] => US [patent_app_date] => 1996-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6377 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852001.pdf [firstpage_image] =>[orig_patent_app_number] => 772620 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/772620
Method and compounds for inhibition of ribonucleases Dec 22, 1996 Issued
Array ( [id] => 4013738 [patent_doc_number] => 05962675 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Chemical syntheses of 2\'-O-methoxy purine nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/780008 [patent_app_country] => US [patent_app_date] => 1996-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 11978 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962675.pdf [firstpage_image] =>[orig_patent_app_number] => 780008 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/780008
Chemical syntheses of 2'-O-methoxy purine nucleosides Dec 22, 1996 Issued
Array ( [id] => 4064143 [patent_doc_number] => 05866548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Caged membrane-permeant inositol phosphates' [patent_app_type] => 1 [patent_app_number] => 8/769665 [patent_app_country] => US [patent_app_date] => 1996-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 17446 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866548.pdf [firstpage_image] =>[orig_patent_app_number] => 769665 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/769665
Caged membrane-permeant inositol phosphates Dec 18, 1996 Issued
Array ( [id] => 3859911 [patent_doc_number] => 05795756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Method and compounds for the inhibition of adenylyl cyclase' [patent_app_type] => 1 [patent_app_number] => 8/762833 [patent_app_country] => US [patent_app_date] => 1996-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11374 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795756.pdf [firstpage_image] =>[orig_patent_app_number] => 762833 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/762833
Method and compounds for the inhibition of adenylyl cyclase Dec 9, 1996 Issued
Array ( [id] => 3790159 [patent_doc_number] => 05840879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Reagents and solid supports for improved synthesis and labeling of polynucleotides' [patent_app_type] => 1 [patent_app_number] => 8/761711 [patent_app_country] => US [patent_app_date] => 1996-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8409 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840879.pdf [firstpage_image] =>[orig_patent_app_number] => 761711 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/761711
Reagents and solid supports for improved synthesis and labeling of polynucleotides Dec 5, 1996 Issued
Array ( [id] => 3775661 [patent_doc_number] => 05808035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Protected nucleoside and method for its synthesis' [patent_app_type] => 1 [patent_app_number] => 8/760591 [patent_app_country] => US [patent_app_date] => 1996-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9097 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808035.pdf [firstpage_image] =>[orig_patent_app_number] => 760591 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/760591
Protected nucleoside and method for its synthesis Dec 3, 1996 Issued
Array ( [id] => 3793093 [patent_doc_number] => 05780449 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Cathepsin G-inhibiting aptamers' [patent_app_type] => 1 [patent_app_number] => 8/753054 [patent_app_country] => US [patent_app_date] => 1996-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3191 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780449.pdf [firstpage_image] =>[orig_patent_app_number] => 753054 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/753054
Cathepsin G-inhibiting aptamers Nov 18, 1996 Issued
Array ( [id] => 3860073 [patent_doc_number] => 05792773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'L-.beta.-dioxolane uridine analog administration for treating Epstein-Barr virus infection' [patent_app_type] => 1 [patent_app_number] => 8/749263 [patent_app_country] => US [patent_app_date] => 1996-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11690 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792773.pdf [firstpage_image] =>[orig_patent_app_number] => 749263 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/749263
L-.beta.-dioxolane uridine analog administration for treating Epstein-Barr virus infection Nov 14, 1996 Issued
Array ( [id] => 3828748 [patent_doc_number] => 05783689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Antibacterial and antifungal nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/745732 [patent_app_country] => US [patent_app_date] => 1996-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9103 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783689.pdf [firstpage_image] =>[orig_patent_app_number] => 745732 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/745732
Antibacterial and antifungal nucleosides Nov 11, 1996 Issued
08/747103 1-(3-AMINOINDAZOL-5-YL)-3-BUTYL-CYCLIC UREA USEFUL AS A HIV PROTEASE INHIBITOR Nov 7, 1996 Abandoned
Array ( [id] => 3861159 [patent_doc_number] => 05792841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => '2\'-halomethylidene, 2\'-ethenylidene and 2\'-ethynl cytidine, uridine and guanosine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/744652 [patent_app_country] => US [patent_app_date] => 1996-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13469 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792841.pdf [firstpage_image] =>[orig_patent_app_number] => 744652 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/744652
2'-halomethylidene, 2'-ethenylidene and 2'-ethynl cytidine, uridine and guanosine derivatives Nov 5, 1996 Issued
Array ( [id] => 3833290 [patent_doc_number] => 05814616 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen' [patent_app_type] => 1 [patent_app_number] => 8/744203 [patent_app_country] => US [patent_app_date] => 1996-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7650 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814616.pdf [firstpage_image] =>[orig_patent_app_number] => 744203 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/744203
Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen Nov 4, 1996 Issued
08/666525 NOVEL NUCLEOSIDE-LIPID ADDITION COMPOUNDS THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE Oct 27, 1996 Abandoned
Array ( [id] => 3775852 [patent_doc_number] => 05808047 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Process for the preparation of 2,2\'-anhydro- and 2\'-keto-1-(3\',5\'-di-O-protected-.beta.-D-arabinofuranosyl) nucleosides' [patent_app_type] => 1 [patent_app_number] => 8/732947 [patent_app_country] => US [patent_app_date] => 1996-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3217 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808047.pdf [firstpage_image] =>[orig_patent_app_number] => 732947 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/732947
Process for the preparation of 2,2'-anhydro- and 2'-keto-1-(3',5'-di-O-protected-.beta.-D-arabinofuranosyl) nucleosides Oct 16, 1996 Issued
Array ( [id] => 3769994 [patent_doc_number] => 05733890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Adenylate analogs as potent anti-herpes virus agents' [patent_app_type] => 1 [patent_app_number] => 8/727292 [patent_app_country] => US [patent_app_date] => 1996-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3998 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733890.pdf [firstpage_image] =>[orig_patent_app_number] => 727292 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/727292
Adenylate analogs as potent anti-herpes virus agents Oct 8, 1996 Issued
Array ( [id] => 4006581 [patent_doc_number] => 05859234 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => '2\'-O-methyl cytidine monomer useful in oligonucleotide synthesis' [patent_app_type] => 1 [patent_app_number] => 8/727139 [patent_app_country] => US [patent_app_date] => 1996-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5274 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859234.pdf [firstpage_image] =>[orig_patent_app_number] => 727139 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/727139
2'-O-methyl cytidine monomer useful in oligonucleotide synthesis Oct 7, 1996 Issued
08/726098 TREATMENT OF DISEASES CAUSED BY PARASITIC PROTOZOA AND FUNGAL DISEASES BY ADMINISTRATION OF 5 -DEOXY- 5 -(SUBSTITUTED)ETHYLTHIORIBOSE COMPOUNDS Oct 3, 1996 Issued
Array ( [id] => 3969262 [patent_doc_number] => 05886165 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Mixed backbone antisense oligonucleotides containing 2\'-5\'-ribonucleotide- and 3\'-5\'-deoxyribonucleotides segments' [patent_app_type] => 1 [patent_app_number] => 8/719970 [patent_app_country] => US [patent_app_date] => 1996-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 8488 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886165.pdf [firstpage_image] =>[orig_patent_app_number] => 719970 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/719970
Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments Sep 23, 1996 Issued
08/707776 6-O-SUBSTITUTED ERYTHROMYCIN KETOLIDES HAVING ANTIBACTERIAL ACTIVITY Sep 3, 1996 Abandoned
Array ( [id] => 3888742 [patent_doc_number] => 05777099 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'RNA separation' [patent_app_type] => 1 [patent_app_number] => 8/706260 [patent_app_country] => US [patent_app_date] => 1996-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3723 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/777/05777099.pdf [firstpage_image] =>[orig_patent_app_number] => 706260 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/706260
RNA separation Sep 3, 1996 Issued
Menu